Company Filing History:
Years Active: 1988-1990
Title: Innovations of John M Braughler
Introduction
John M Braughler is an accomplished inventor based in Portage, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of steroid prodrugs. With a total of two patents to his name, Braughler's work has implications for medical treatments and therapies.
Latest Patents
Braughler's latest patents include the invention of an 11a-hydroxy steroid diester. This invention relates to 21-(3-carboxy-1-oxopropoxy)-17.alpha.-hydroxy-11.alpha.-(3,3-dimethyl-1-oxobutoxy)pregna-1,4-diene-3,20-dione and pharmaceutically acceptable salts thereof, which are useful steroid prodrugs. Another notable patent involves the inhibition of angiogenesis through the coadministration of steroids. This method aims to inhibit angiogenesis in warm-blooded animals by administering an anti-angiogenic effective amount of a specific compound.
Career Highlights
Braughler has had a notable career at The Upjohn Company, where he has focused on innovative pharmaceutical solutions. His work has contributed to advancements in steroid therapies and their applications in medical treatments.
Collaborations
Throughout his career, Braughler has collaborated with esteemed colleagues, including Edward Dallas Hall and John M McCall. These collaborations have fostered a productive environment for innovation and research.
Conclusion
John M Braughler's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective medical treatments.